The controversial subject of labeling of "biotech foods" in the United States recently has been reinvigorated by several occurrences. These occurrences include the introduction of new legislation requiring the special labeling of foods (including meat and poultry) produced by modern biotechnology (H.R. 3377,1999); the spillover effects of the European debate about "Frankenstein" foods (Klee, 1999) and requisite European Union (EU) labeling requirements (EU, 1998); a suit against the Food and Drug Administration (FDA) demanding mandatory labeling, among other things (Alliance for Biointegrity v. Shalala, 1998); and three public hearings on the subject of biotech food labeling and other topics (FDA, 1999a). Demands for labeling because of the consumer's "right-to-know" also have complicated the labeling debate.
展开▼
机译：最近在美国引起争议的“生物技术食品”标签主题因多次出现而重新焕发了活力。这些事件包括引入新的立法，要求对由现代生物技术生产的食品（包括肉类和家禽）进行特殊标记（H.R. 3377，1999）；欧洲有关“弗兰肯斯坦”食品的辩论（Klee，1999年）和必需的欧盟（EU）标签要求（EU，1998年）的溢出效应；针对食品药品管理局（FDA）的要求强制性标签的诉讼，其中包括（Alliance for Biointegrity v。Shalala，1998）；以及关于生物技术食品标签和其他主题的三场公开听证会（FDA，1999a）。由于消费者的“知情权”而对标签的要求也使标签辩论变得复杂。
展开▼
